International Herald Tribune, June 23 Washington Post Critics Denounce Empty Promises of Tobacco Deal By John Schwartz and Saundra Torry Washington Post Service WASHINGTONHaving had a look at the fine print of the 68page settlement proposal between tobacco companies and state attorneys general, the critics are lining up to take their shots. "Overall, this is a document filled with empty promises and unfilled commitments," said David Vladeck, a regulatory law expert and head of the Public Citizen Litigation Group, expressing the view of consumer groups that the agreement was too favorable to the tobacco industry. David Kessler, the former Food and Drug Administration commissioner who is now consulting with the federal government on tobacco regulation, said there were some "wonderful" provisions in the plan, including the part that provided for antitobacco education campaigns. But he also said he had "very serious concerns" about the parts of the deal he has seen so farthose regarding the food and drug agency's jurisdiction over tobacco and other components of cigarettes. "We will ask the public health groups to come back this week and review the details of the settlement linebyline," Mr. Kessler said. Mr. Vladeck said the document "reflects the technical sophistication of the tobacco industry lawyers" compared with the "neophyte" status of the other side on regulatory issues. "I am not saying the attorneys general deliberately took a fall, but they came in second and not even a close second. " He was particularly critical of provisions in the settlement that say the food and drug agency would have to prove that attempts to limit nicotine or other substances in tobacco products would neither be detrimental to public health nor create a black market. The attorney general of Mississippi, Michael Moore and his colleagues said the provisions simply reflected con cerns expressed by health officials that they did not yet have scientific evidence to justify taking such moves against tobacco products. Mr. Vladeck said that rule set the bar almost impossibly high. Other phrases and concepts scattered throughout the document, Mr. Vladeck said, turn seeming public health advances into regulatory traps that weigh heavily in the industry's favor. For instance, any attempt by the government to limit nicotine would require a "formal rulemaking" procedure, as opposed to the easier procedure the food and drug agency uses for most regulations, including its 1996 tobacco rule. In addition, Michael McGinnis, a former official of the Department of Health and Human Services, said the $1 billion annual fund for smoking cessation programs could well be too small to meet the needs of the nation's 45 million smokers. Other critics of the planwhich must gain the approval of Congress and President Bill Clintonsay the proposed fines against the companies if they miss targets for reducing youth smoking are too Iow. "Look at all those smokers they can get just by paying that money," said Richard Kluger, author of "Ashes to Ashes," a PulitzerPrize winning study of the cigarette industry. More fierce criticism came from Bennett LeBow head of the cigarette maker, Liggett Group Inc. Earlier this year, Mr. LeBow signed a separate settlement with 22 attorneys general. Mr. LeBow said that he saw a lot of good news in the public health portion of the larger proposal, but that the industry got off easy, especially when it comes to the kinds of internal papers it will have to make public. The companies involved in the negotiations agreed to turn over scientific documents, but not the highly sensitive documents Mr. LeBow agreed to provide. "They are giving up zero" he said. The other companies are fighting release of Mr. LeBow's documents, which could shed light on the entire industry. Noting that the tobacco giants began negotiations with attorneys general just weeks after the announcement of his deal, Mr. LeBow said it was easy to figure out "why they're trying to rush to a deal quick. " While the tobacco companies received some protection from the federal regulation in the deal, in its pact the weaker Liggett agreed to be governed by the full food and drug agency rule. Recalling the remark by the attorneys general that they had held up the deal to protect a whistleblower; Jeffrey Wigand, because they did not want to "leave anybody on the beach," Mr. LeBow said: "They left us on the beach. We are the ultimate whistleblowers." 'Bitter Pill' for the Industry Barnaby J. Feder of The New York Times reported: In reaching an agreement that would cost them billions of dollars a year and poses the potential to chase away customers, cigarette companies calculated that they still would be left with sufficiently lucrative business and would not continue to be haunted by lawsuits that have depressed their stock prices, consumed ever more of their resources and given their industry an image as America's corporate rogue. The tobacco settlement would cost the highly profitable industry an average of $14.7 billion a year over the next 25 years, more than twice its profits from domestic cigarette sales in 1996. The industry called that and other terms of the deal a "bitter pill." But the companies' stock prices have risen in the two months since negotiations on a settlement began, a sign of investor recognition that the companies have much to gain from an agreement even as they pay what looks like a steep price. Although the combative tobacco industry has had great success in the courts at defeating lawsuits brought by sick smokers, it came under enough pressure in the last several years to force it to the bargaining table for the first time in four decades of nasty battles over the health effects of tobacco. Central elements of that pressure were the lawsuits brought by more than three dozen states in an effort to recover Medicaid costs of smokingrelated illnesses. At the same time, the industry was confronted with the very real prospect of vastly expanded federal regulation, which is not the case under the agreement. Wall Street has no doubt that the manufacturers, whose cigarette sales in the United States amount to $45 billion a year, would be able to survive the costs of the agreement by raising prices, though just how prosperous they would be under the restrictions in the settlement is still very much in doubt. In the end, Wall Street is betting there will still be tens of millions of American smokers, and the industry leadersthe Philip Morris Companies, RJR Nabisco Holdings Corp. and BAT Industries PLC, the British parent of Brown & Williamson Tobacco Corp. will continue to enjoy domestic profits that many other industries dream of emulating. Investors are further betting that whatever those cigarette makers lose in the United States they will make up for overseas, where they are already enjoying strong growth. Emanuel Goldman, who follows the industry for Paine Webber, said if Congress enacts the deal, "the companies' stock prices could go up another 20 percent" over the next 12 months. Although Philip Morris, for example, has nearly half the domestic cigarette market, and so would have the biggest liabilities from the settlement, its tobacco business derives just 30 percent of its earnings from the United States, compared with 50 percent for Reynolds and even higher percentages for other rivals.